Transthoracic fine-needle aspiration. Experience in a cancer center

Cancer. 1985 Nov 15;56(10):2504-7. doi: 10.1002/1097-0142(19851115)56:10<2504::aid-cncr2820561030>3.0.co;2-a.

Abstract

The authors summarize 5 years' experience with transthoracic fine-needle aspiration (TFNA) in 180 patients. Aspirated tumors tended to be large and peripheral. A large pneumothorax was seen after 4.3% of aspirations, and various minor complications followed another 23.3%. Emphysema was a significant risk factor for complications. Follow-up confirmed 151 cancers, with a wide variety of origins and histologic types. In the diagnosis of cancer, TFNA cytology had a specificity of 100% and a sensitivity of 82%. Positive TFNA findings usually provided the earliest microscopic diagnosis of cancer or of cancer stage.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Biopsy, Needle / adverse effects
  • Biopsy, Needle / methods
  • Cancer Care Facilities
  • Diagnostic Errors
  • Emphysema / etiology
  • Female
  • Follow-Up Studies
  • Humans
  • Lung Neoplasms / diagnostic imaging
  • Lung Neoplasms / pathology*
  • Lung Neoplasms / secondary
  • Male
  • Medical Oncology / methods*
  • Middle Aged
  • Norway
  • Radiography